Author

D. T. Dicker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Lev· 1 shared J. Sanders· 1 shared J. Santiago· 1 shared L. Hernandez Borrero· 1 shared L. Zhou· 1 shared N. Ahsan· 1 shared W. S. El-Deiry· 1 shared X. Tian· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Lev

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A subset of CB002 xanthine analogues bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53

L. Hernandez Borrero, D. T. Dicker, J. Santiago, J. Sanders, X. Tian, N. Ahsan, A. Lev, L. Zhou, W. S. El-Deiry

The paper identifies CB002 analogues that restore p53 signaling and target an S-phase checkpoint in p53-mutated tumors, inducing apoptosis and reducing proliferation without harming normal cells.

eLife · Jul 29, 2021Peer-reviewedCancer Biology